Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Reducing Risky Drug Use Behaviors by Enrolling Syringe Exchange Registrants in Methadone Maintenance

Bibliographic Data

ID21645674
AuthorsMichael Kidorf (0000-0002-6346-3315, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA, corresponding author), Robert K Brooner (Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA), Jeannie‐marie Leoutsakos (0000-0002-1010-1046, Johns Hopkins University), Jeannie-Marie Leoutsakos (Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA), Jessica M Peirce (0000-0002-1192-3965, Johns Hopkins University), Jessica Peirce (Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA)
Year2021
Volume56
Issue4
Pages546-551
Publication date2021-03-21
Open AccessNo
TypeARTICLE
VenueSubstance Use & Misuse (JOURNAL)
Journal identifiersISSN: 1082-6084 • E-ISSN: 1532-2491
PublisherInforma UK Limited (PUBLISHER • GB)
DOI10.1080/10826084.2021.1887253
PMID33616479
OpenAlexW3129723204
LanguageEN
References cited28

Background Referral of syringe exchange registrants with opioid use disorder to agonist treatment provides a pathway to further reduce drug use risk behaviors. Objective: This study evaluates the drug use risk reduction benefits of enrolling syringe exchange registrants in methadone maintenance, and the impact of continued illicit drug use on risk reduction. Method: Baltimore Needle Exchange Program (BNEP) registrants (n = 210) participated in a parent study evaluating treatment initiation strategies for methadone maintenance and were followed for six months. The Risk Assessment Battery (RAB; Metzger, 1993 Metzger, D. (1993). The Risk Assessment Battery (RAB): Validity and reliability. In Presented at the annual meeting of the National Cooperative Vaccine Development Group for AIDS. Alexandria, VA: Alcohol and Drug Abuse Institute, University of Washington. [Google Scholar]) was administered monthly to evaluate drug use risks; urinalysis testing was conducted weekly. Results: Treatment enrollment reduced drug use risk behaviors, and longer treatment episodes resulted in additional, though modest, risk reduction. Use of opioids or cocaine in treatment diminished risk-reduction benefits, though drug use risks declined over time and remained well below baseline levels. Conclusions: These findings demonstrate that methadone maintenance enhances the well-known risk-reduction benefits of syringe exchange participation. Improving coordination between syringe exchanges and treatment facilities may enhance the public health

Addiction · Drug · Environmental health · Harm reduction · Heroin · Methadone · Methadone maintenance · Psychiatry · Public health · Substance abuse · Syringe · HIV, Drug Use, Sexual Risk · Medicine · Nursing · Opioid Use Disorder Treatment · Substance Abuse Treatment and Outcomes · Emergency Medicine

  • Mortality risk during and after opioid substitution treatment

    Open Access•Luis Sordo, Gregorio Barrio et al.•BMJ•2017

  • Retention in medication-assisted treatment for opiate dependence

    Christine Timko, Nicole R Schultz et al.•Journal of Addictive Diseases•2016

  • Drug Dependence, a Chronic Medical Illness

    A Thomas McLellan, David C Lewis et al.•JAMA•2000

  • Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs

    Esther J Aspinall, Dhanya Nambiar et al.•International Journal of…•2014

  • Psychosocial and Behavioral Differences Among Drug Injectors who Use and do not Use Syringe Exchange Programs

    Open Access•Lauretta E Grau, Ricky N Bluthenthal et al.•AIDS and Behavior•2005

  • Distributive Syringe Sharing and Use of Syringe Services Programs (SSPs) Among Persons Who Inject Drugs

    Open Access•Monica Adams, Qian An et al.•AIDS and Behavior•2019

  • HIV Prevention Among Injection Drug Users

    David S Metzger•Journal of Urban Health•2003

  • Opioid Agonist Treatments and Heroin Overdose Deaths in Baltimore, Maryland, 1995–2009

    Robert P Schwartz, Jan Gryczynski et al.•American Journal of Public Health•2013

Highly citedNo

Tools

Open DOI
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae